Trials / Active Not Recruiting
Active Not RecruitingNCT05987553
The Influence of an E-learning Program on Recognition of Actinic Keratosis
The Influence of an E-learning Program on Recognition of Actinic Keratosis by General Practitioners). Implementation of Actinic Keratosis Guidelines Among General Practitioners.
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- Maastricht University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 67 Years
- Healthy volunteers
- Not accepted
Summary
The evaluation on the diagnostic accuracy of actinic keratosis recognition by general practitioners before and after participation on an e-learning program.
Detailed description
Actinic keratosis is defined as the most frequent common intra-epithelial neoplasm in the Caucasian population, with an increasing prevalence. If left untreated, actinic keratosis has the potency to develop into a cutaneous squamous-cell carcinoma. Treatment of actinic keratosis is aimed at both lesion reduction and to prevent malignant transformation. To achieve treatment adherence for patients, it is necessary to raise physician awareness about actinic keratosis. This study primarily aimed to investigate whether the sensitivity of establishing a correct actinic keratosis diagnosis by general practitioners (in training) would increase after participating in an e-learning program about the recognition of actinic keratosis. This was achieved by comparing the results of a pre- and post-test completed by general practitioners which was incorporated in the e-learning program.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | e-learning program | All participants participate in this intervention: an e-learning program about the recognition of actinic keratosis. The program exists of 30 cases. Each case exists of a question and thorough explanation including references to various sources. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2024-01-01
- Completion
- 2025-12-01
- First posted
- 2023-08-14
- Last updated
- 2025-04-04
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05987553. Inclusion in this directory is not an endorsement.